Member Info for Mars1

Well it looks like we are moving to the next level of testing it will not just be airports and we know what that should mean

Heathrow boss said on BBC that govt are working on an alternative to quarantine but they are not ready

57% test positive
https://www.google.co.uk/amp/s/indianexpress.com/article/cities/mumbai/mumbai-sero-survey-results-coronavirus-bmc-6527865/lite/

From the article below “ On Tuesday, India's top medical research agency, the Indian Council of Medical Research (ICMR), said about 528,082 COVID-19 tests were conducted across the world's second-most populous nation, which has more than 1.3 billion people.

To ramp up testing capacity, Prime Minister Narendra Modi on Monday launched three facilities in Mumbai, Kolkata and Noida on the outskirts of Delhi. Officials said each facility is capable of testing as many as 10,000 samples a day.”
https://www.google.co.uk/amp/s/www.aljazeera.com/amp/news/2020/07/months-experts-india-coronavirus-crisis-200727091515912.html

Are Kodak to build organically or by acquisition?

http://health.mp.gov.in/sites/default/files/2020-04/GOI_Order/17.04.2020%20Protocol%20Rapid%20Antibody%20test.pdf

One thing I have wondered about is how long does it take the Regulator to test a 20 min lateral test? As long as an Elisa/laboratory result test?

This may have been posted earlier apologies if it has. Taken from the article below “ The prevalence of post-COVID-19 fibrosis will become apparent in time, but early analysis from patients with COVID-19 on discharge from hospital suggests a high rate of fibrotic lung function abnormalities. Overall, 51 (47%) of 108 patients had impaired gas transfer and 27 (25%) had reduced total lung capacity. ”
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30225-3/fulltext

Shandy Japan is in Asia no need to highlight separately. Japanese companies tend to market into Asia do contracts do not tend to be just domestic to them.

Over 4m cases in US and still counting it is those that recover with lung fibrosis that NXP002 may help more than likely a post Covid drug.

Depends on US buying

Bloomberg have it listed
https://www.bloomberg.com/news/articles/2020-07-18/u-k-coronavirus-antibody-test-passes-trial-telegraph-reports?in_source=postr_story_2

Alternatively Dido may have saved a lot of PI’s on Friday. 1p over 40p before news breaking they may have cashed in their OO shares for a ‘profit!!’ They will make one now hopefully everyone will wait for £’s

What I found interesting is ODX have a virtual monopoly for CD4 visited as PEPFAR have announced they will only use lateral flow poc tests for HIV and there is only one in the market. It is only PEPFAR (USpresidents fund) and WHO global fund who finance these test 4m to 6m pa

Just tried the link got a 404 error

Take off 11m cash this co is value is £47m equivalent to 15 weeks profit at full production

Results from RNS 9th June
“ Further to the announcement on 2 April 2020, the Company now expects EBITDA for the year ended 31 March 2020 to be in a range of £850k to £900k, which is slightly ahead of market expectations. ” the write off is below the line as just a book entry.

Company has done everything said it would on schedule Including freeze. Next is 100k tests in August, 200k in Sept. cannot control sp.

This is the wording I found interesting “ to assist in understanding the prevalence of the coronavirus across England”. Does this mean they are going to antigen and antibody test everyone.

Was anything said about the lung tissue damage post Covid?